INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
Jun. 30, 2018 |
Jun. 30, 2017 |
|
| Operating expenses: | ||||
| Research and development, net | $ 1,481 | $ 435 | $ 2,458 | $ 1,376 |
| General and administrative | 1,606 | 640 | 2,936 | 1,469 |
| Operating loss | (3,087) | (1,075) | (5,394) | (2,845) |
| Financial expenses (income), net | 4 | (35) | (5) | (20) |
| Net loss | $ (3,091) | $ (1,040) | $ (5,389) | $ (2,825) |
| Basic and diluted net loss per share from continuing operations | $ (0.16) | $ (0.06) | $ (0.28) | $ (0.15) |
| Weighted average number of shares outstanding used in computing basic and diluted net loss per share | 19,505,157 | 18,738,496 | 19,277,518 | 18,713,575 |